memo - Magazine of European Medical Oncology
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Recent developments in the palliative treatment of breast cancer: ASCO 2013
memo - Magazine of European Medical Oncology - Tập 6 - Trang 233-235 - 2013
Highly selected abstracts from the ASCO meeting are reported. Abstract #1040: Subgroup analysis of TURANDOT (first-line paclitaxel and bevacizumab (T + BEV) versus capecitabine and BEV) was presented; 130 patients had triple-negative disease. One-year overall survival of T + BEV-treated patients with triple-negative disease was 78 %. Thus, T + BEV may represent a preferred regimen. Abstract #514: ...... hiện toàn bộ
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia
memo - Magazine of European Medical Oncology - Tập 13 - Trang 227-234 - 2020
Chronic primary immune thrombocytopenia (ITP) is an autoimmune disease involving the formation of antibodies to thrombocytes, leading to increased platelet destruction and chronic thrombocytopenia. Additionally, impaired platelet production is due to relative thrombopoietin deficiency. Romiplostim, a thrombopoietin receptor agonist, normalized platelet counts in affected patients in randomized con...... hiện toàn bộ
Novel therapeutic concepts in multiple myeloma
memo - Magazine of European Medical Oncology - Tập 2 - Trang 5-9 - 2009
Treatment of multiple myeloma (MM) has evolved greatly over the past decade, and owing to immunomodulatory agents (thalidomide and lenalidomide) and proteasome inhibition (bortezomib), patients with MM enjoy prolonged survival and improved quality of life. Use of these novel agents has improved the rate of complete remissions in MM, a parameter that has emerged as an important step towards improve...... hiện toàn bộ
Highlights in the adjuvant treatment of colon cancer from annual meetings 2011
memo - Magazine of European Medical Oncology - Tập 5 Số 2 - Trang 163-166 - 2012
The outcome of COVID-19 in patients with hematological malignancy
memo - Magazine of European Medical Oncology - Tập 15 - Trang 83-89 - 2021
The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall survival, and to determine the factors affecting mortality. This retrospective study included 77 patients with hematological cancer and COVID-19. Patients were sub-grouped for analysis as survivors and non-survivors. COVID-19 was seen more frequently in myelo...... hiện toàn bộ
ASCO 2019—Personal highlights on adjuvant breast cancer: (neo-)adjuvant therapy of HER2-negative HR-positive BC
memo - Magazine of European Medical Oncology - Tập 12 - Trang 305-307 - 2019
This article intends to summarize personal highlights from the 2019 ASCO (American Society of Clinical Oncology) Annual meeting. The article does not aim to offer a comprehensive summary of the 1642 abstracts presented, but rather aims to highlight the abstracts that are the most relevant for the neo/adjuvant therapy of the HER2-negative, HR-positive breast cancer. By doing so, the article generat...... hiện toàn bộ
Stem cell transplantation for acute myeloid leukaemia in adults
memo - Magazine of European Medical Oncology - Tập 7 - Trang 227-230 - 2014
Gone are the days when a patient with acute myeloid leukaemia (AML) would die waiting for a suitable donor for allogenic stem cell transplantation. With improved supportive care, we can now confidently provide unrelated donor transplant to most patients. The adult patient who does not have a suitable donor can be considered to have a haploidentical transplant or a cord transplant. In fact, a combi...... hiện toàn bộ
Obituary for Dr. Ferdinand Ploner
memo - Magazine of European Medical Oncology - Tập 8 Số 4 - Trang 201-201 - 2015
Current and evolving treatment strategies in adult immune thrombocytopenia
memo - Magazine of European Medical Oncology - Tập 11 - Trang 241-246 - 2018
Immune thrombocytopenia (ITP) is an acquired autoimmune phenomenon resulting in low platelet count and increased bleeding risk. Goals of upfront management include prompt control of severe bleeding—which is rare—as well as induction and maintenance of a hemostatic platelet count. Thus, optimal management of ITP patients is often challenging and requires a highly individualized approach. Many patie...... hiện toàn bộ
Tổng số: 854
- 1
- 2
- 3
- 4
- 5
- 6
- 10